TMPEA-5:
669 ·
883
Bailey, K; Legault, D. 13C NMR spectra and structure of mono-, di- and trimethoxyphenylethylamines and amphetamines. Org. Magn. Resonance, 1 Jun 1983, 21 (6), 391–396. 680 kB. https://doi.org/10.1002/omr.1270210611
Clark, LC; Benington, F; Morin, RD. The effects of ring-methoxyl groups on biological deamination of phenethylamines. J. Med. Chem., 1 May 1965, 8 (3), 353–355. 389 kB. https://doi.org/10.1021/jm00327a016
Matsuhiro, B; Furst, A. 2,3,6-Trimethoxynitrostyrene and its β-phenethylamine. J. Med. Chem., 1 Sep 1970, 13 (5), 973. 140 kB. https://doi.org/10.1021/jm00299a042
Brimblecombe, RW; Pinder, RM. Hallucinogenic agents, Wright-Scientechnica, Bristol, UK, 1 Jan 1975. 46.2 MB. #Page 62
Merchant, J; Mountwala, A. Synthesis of some β-phenethylamine derivatives. I. J. Org. Chem., 1 Nov 1958, 23 (11), 1774-1776. 359 kB. https://doi.org/10.1021/jo01105a601 #XIV
4-D · 4-Trideuteromescaline
β,β-Dideuteromescaline · β-D
2,4,6-TMPEA · 2C-TMA-6 · TMPEA-6 · ψ-2C-O
3,5-D · 3,5-Di(trideutero)mescaline
2,6-D · 2,6-Dideuteromescaline
α,α-Dideuteromescaline · α-D
Isoprenaline · β,3,4-HO-N-iPr-DHPEA
N-Me-DME · Normacromerine
N-Methyl-3,4,5-trimethoxybenzylamine
α,β-D · α,β-Dideuteromescaline